SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001179110-19-012054
Filing Date
2019-11-26
Accepted
2019-11-26 07:46:57
Documents
1
Period of Report
2019-11-25

Document Format Files

Seq Description Document Type Size
1 FORM 4 - edgar.html 4  
1 FORM 4 - edgar.xml 4 5327
  Complete submission text file 0001179110-19-012054.txt   6883
Mailing Address 375 PHEASANT RUN NEWTOWN PA 18940
Business Address 375 PHEASANT RUN NEWTOWN PA 18940 267-759-3681
Onconova Therapeutics, Inc. (Issuer) CIK: 0001130598 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O SPECTRUM PHARMACEUTICALS 11500 SOUTH EASTERN AVENUE, SUITE 240 HENDERSON NV 89052
Business Address
OLER ABRAHAM N. (Reporting) CIK: 0001557372 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36020 | Film No.: 191247577